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Abstract. 
 
Long-term functional plasticity in the ner-
vous system can involve structural changes in terminal 
arborization and synaptic connections. To determine 
whether the differential expression of intrinsic neu-
ronal determinants affects structural plasticity, we pro-
duced and analyzed transgenic mice overexpressing the 
cytosolic proteins cortical cytoskeleton–associated pro-
tein 23 (CAP-23) and growth-associated protein 43 
(GAP-43) in adult neurons.
Like GAP-43, CAP-23 was downregulated in mouse 
motor nerves and neuromuscular junctions during the 
second postnatal week and reexpressed during regener-
ation. In transgenic mice, the expression of either pro-
tein in adult motoneurons induced spontaneous and 
greatly potentiated stimulus-induced nerve sprouting at 
the neuromuscular junction. This sprouting had trans-
gene-specific features, with CAP-23 inducing longer, 
but less numerous sprouts than GAP-43. Crossing of 
the transgenic mice led to dramatic potentiation of the 
sprout-inducing activities of GAP-43 and CAP-23, indi-
cating that these related proteins have complementary 
and synergistic activities. In addition to ultraterminal 
sprouting, substantial growth of synaptic structures was 
induced. Experiments with pre- and postsynaptic toxins 
revealed that in the presence of GAP-43 or CAP-23, 
sprouting was stimulated by a mechanism that responds 
to reduced transmitter release and may be independent 
of postsynaptic activation.
These results demonstrate the importance of intrinsic 
determinants in structural plasticity and provide an ex-
perimental approach to study its role in nervous system 
function.
 
T
 
he
 
 formation of neuronal connections involves a se-
quence of distinct stages in axonal growth, i.e., long-
distance elongation, growth of collaterals to reach
the target region, and innervation of target cells. Terminal
arborization initiates the final phase of the innervation
process. This dynamic process provides the presynaptic
substrate for the formation and activity-sensitive refine-
ment of synaptic connections during development. In the
adult , it can be reactivated by local deafferentation, lead-
ing to sprouting and reinnervation (e.g., Brown, 1984). In
addition, there is now substantial evidence supporting the
view that the dramatic extent of learning-induced func-
tional plasticity in the adult vertebrate nervous system also
involves local changes in terminal arborization and synap-
tic connections (see e.g., Bailey et al., 1994; Darian-Smith
and Gilbert, 1994; Das and Gilbert, 1995). Because of the
fact that terminal arborization plays such a central role in
nervous system plasticity, it is of great interest to define
the mechanisms that promote and regulate this process.
One factor that affects nerve sprouting and terminal ar-
borization is the expression of competence conferring com-
ponents in responding neurons (Skene, 1989; Woolf et al.,
1992; Aigner et al., 1995). These include specific receptors
for extracellular signals, as well as corresponding signal
transduction and growth machinery to translate defined
signals into local growth. The neural protein kinase C
(PKC)
 
1
 
 substrate growth-associated protein 43 (GAP-43)
is a cytosolic growth cone and nerve terminal protein that
promotes local nerve growth and appears to belong to the
latter category (for reviews see Benowitz and Routten-
berg, 1987; Skene, 1989; Liu and Storm, 1990). This axonal
protein is expressed during nerve elongation and terminal
arborization and is usually downregulated when synaptic
rearrangements are completed, but its expression is selec-
tively maintained in defined types of neurons in the adult.
Although GAP-43 is not required for nerve growth (Stritt-
matter et al., 1995), the existence of a strong correlation
between its expression in the developing and adult ner-
vous system and competence for nerve sprouting suggests
that GAP-43 may potentiate local nerve growth. This view
received support from the recent demonstration that over-
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expression of GAP-43 in the neurons of adult transgenic
mice leads to spontaneous and greatly potentiates induced
nerve sprouting (Aigner et al., 1995). The results with
GAP-43 have raised the possibility that the expression of
growth- and plasticity-associated proteins in neurons may
promote their growth responses to local signals. This hy-
pothesis predicts that intrinsic growth–promoting proper-
ties are not restricted to GAP-43 and that neurons may ex-
press diverse sets of plasticity-promoting proteins. Such
proteins would act downstream of signal transduction
pathways initiated by extracellular ligands to promote the
translation of receptor activation into cytoskeletal rear-
rangements and local growth. Expression of particular
combinations of these proteins may affect the intrinsic
competence of neurons for local structural plasticity.
One protein that may be functionally related to GAP-43
is the cortical cytoskeleton-associated protein CAP-23 (Wid-
mer and Caroni, 1990). Although GAP-43 and CAP-23 do
not have homologous sequences, they share several char-
acteristic biochemical properties. These include: 1) Both
proteins bind calmodulin and are phosphorylated by PKC
in a mutually exclusive manner (Liu and Storm, 1990;
Maekawa et al., 1993, 1994); 2) they have highly hydro-
philic sequences, the same type of unusual amino acid
composition rich in Ala, Pro, Lys, and Glu, and very little
secondary structure (Skene, 1989; Widmer and Caroni,
1990); 3) both are acylated proteins (GAP-43 is palmitoy-
lated [Skene and Virag, 1989], whereas CAP-23 is myris-
toylated [Maekawa et al., 1994]) that colocalize at unique
punctate structures at the cell membrane (Wiederkehr, A.,
and P. Caroni, manuscript submitted for publication) and
interact with the cortical cytoskeleton (Meiri and Gordon-
Weeks, 1990; Moss et al., 1990; Widmer and Caroni, 1990);
and 4) their expression is highly regulated and peaks during
development of the nervous system, when they can repre-
sent up to 0.2% (GAP-43) and 0.8% (CAP-23) of total
brain protein (Skene, 1989; Widmer and Caroni, 1990;
Maekawa et al., 1993). In addition, GAP-43 (Caroni and
Becker, 1992) and CAP-23 (see Fig. 1) are downregulated
and reinduced with comparable kinetics in spinal moto-
neurons, and they induce the same type of characteristic
surface activities in transfected cells (Wiederkehr, A., and
P. Caroni, manuscript submitted for publication).
To determine whether CAP-23 has sprout-promoting
activity and to explore the possibility that neurons may ex-
press growth-promoting proteins with overlapping and/or
synergistic activities, we generated transgenic mice that
constitutively expressed CAP-23 in adult neurons. Like
GAP-43–overexpressing mice, these mice displayed spon-
taneous and greatly potentiated induced nerve sprouting
at the neuromuscular junction. However, the sprouting
patterns in the presence of GAP-43 or CAP-23 were dif-
ferent, and double-transgenic mice expressing both pro-
teins in motoneurons displayed dramatic quantitative and
qualitative potentiation of sprouting. We then carried out
experiments aimed at defining the properties and regula-
tion of the structural plasticity promoted by these growth-
associated proteins. These experiments revealed that: 1) Al-
terations in both nerve growth and postsynaptic structures
were induced at the neuromuscular junction of the trans-
genic mice; 2) growth-promoting pathways are rapidly ac-
tivated by reduced transmitter release, possibly indepen-
dent of muscle nicotinic acetylcholine receptor (AChR)
activation; and 3) paralysis promotes sprout elongation.
 
Materials and Methods
 
Generation of CAP-23 Transgenic Mice
 
The Thy1.2-based expression cassette was as described (Aigner et al.,
1995; see also Vidal et al., 1990). It drives transgene expression specifically
in postnatal mouse neurons, including spinal motoneurons. A description
of its expression properties can be found elsewhere (Caroni, 1996). cDNA
coding for chick CAP-23 (Widmer and Caroni, 1990) was cloned into the
Thy1 expression cassette. To avoid possible regulation of CAP-23 mRNA
stability or translation due to regulatory sequences in the untranslated re-
gions, the cDNA sequences only contained 7 nucleotides of 5
 
9
 
-, and 10 nu-
cleotides of 3
 
9
 
-untranslated region. Seven independent transgenic lines were
generated. Of these, three lines were excluded from further analysis be-
cause of low expression of the transgene, as assayed by immunoblots of
brain homogenates and by immunocytochemistry on skeletal muscle sec-
tions (motor nerve expression). To minimize possible effects due to differ-
ences in genetic background, all lines of GAP-43– and CAP-23–overex-
pressing mice were bred into C57Bl6 mice for at least five generations.
Inbreeding did not appear to affect spontaneous nerve sprouting in the
transgenic mice. However, because of better breeding results, most exper-
iments were carried out in outbred Balb/C 
 
3
 
 C57Bl6 mice. A survey of
mouse tissues revealed no further expression outside the nervous system.
In particular, we found no transgene expression in innervated or dener-
vated muscle, nor in intramuscular Schwann cells (data not shown, but see
Aigner et al., 1995). In the nervous system, we detected prominent expres-
sion in a diverse range of neuronal types in the peripheral nervous system
and central nervous system (see Fig. 2 
 
A
 
), but no expression in GFAP-
positive astrocytes, peripheral nerve Schwann cells, terminal Schwann
cells at the neuromuscular junction, or GalC-positive oligodendrocytes
(data not shown). The transgenic lines were designated as follows: CAP-
23(2, 11, 13, 17), mice expressing chick CAP-23; and GAP-43(wt2, wt3),
mice expressing chick GAP-43 (Aigner et al., 1995).
 
Detection of mRNAs and Proteins
 
In situ hybridization for chick CAP-23 was carried out on frozen sec-
tions with a digoxigenin-labeled cRNA probe, as described (Schaeren-
Wiemers and Gerfin-Moser, 1993; Arber and Caroni, 1995). Total RNA was
isolated and analyzed on Northern blots with digoxigenin-labeled riboprobes,
as described (Arber et al., 1994). A rat cDNA coding for the 
 
g
 
-subunit
of the acetylcholine receptor was a kind gift from A. Buonanno (National
Institutes of Health, Bethesda, MD). For immunoblots, brains were ho-
mogenized in SDS-PAGE sample buffer, protein contents were deter-
mined, and 40 
 
m
 
g of protein were loaded per slot. CAP-23 was visualized
with either monoclonal antibody 15C1 (Widmer and Caroni, 1990), which
specifically detects chick but not mouse CAP-23, or with a rabbit antise-
rum to the carboxyl-terminal residues VASSEQSVAVKE of rat and mouse
neuronal acidic protein 22 (NAP-22). (This antiserum does not crossre-
act with chick CAP-23.) NAP-22 (Maekawa et al., 1993) is the rat ho-
mologue of CAP-23. (The correct carboxyl-terminal sequence of chick
CAP-23 is 171-AETKSEVAPASDSKPSSPSSKETVAATAAPSSTA-
KASDPSAPPEEAKPSEAPATNSDTTIAVQD-234; due to two frame-
shift errors in the 3
 
9
 
-end sequence of the cDNA, the original sequence
[Widmer and Caroni, 1990] contained two translation errors.) GAP-43
was visualized as described (Aigner et al., 1995). Immunocytochemistry
was performed on 12-
 
m
 
m cryostat sections of 4%-formaldehyde–fixed tis-
sues. Antibodies were applied in PBS with 0.5% NP-40 (Sigma Chemical
Co., St. Louis, MO) and 5% BSA as described (Widmer and Caroni,
1990). Monoclonal antibody supernatants were diluted 1:100. Neurofila-
ment-160 was detected with a specific monoclonal antibody (Sigma Chem-
ical Co.). Rhodamine-
 
a
 
-bungarotoxin was from Molecular Probes (Eu-
gene, OR). Bound antibodies were visualized with Biotin-conjugated
second antibodies, followed by Lucifer yellow–conjugated streptavidin,
and with rhodamine-conjugated second antibodies. (All secondary anti-
body reagents were from Molecular Probes.) Postsynaptic neuromuscular
junction configurations were visualized by labeling whole-mount prepara-
tions of gluteus muscle with RITC–
 
a
 
-bungarotoxin. All procedures were
carried out at 4
 
8
 
C. Briefly, muscles were incubated for 5 h in L15/PBS (1:2) 
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with 1 
 
m
 
g/ml of RITC–
 
a
 
-bungarotoxin, rinsed with PBS, and fixed over-
night with 2% paraformaldehyde in phosphate buffer (pH 7.4). Groups of
one to five muscle fibers were then dissected in water and mounted in airvol.
 
Lesion Protocols
 
For most experiments, local paralysis was induced by a single subcutane-
ous injection of 1 pg of purified Botulinum toxin A (kind gift of C. Mon-
tecucco, Pavia, Italy, and S. Catsicas, Geneva, Switzerland) over the right
gluteus maximus or gastrocnemius of 4–6-wk-old mice. For 3-wk paralysis
experiments, a second injection of 0.8 pg Botulinum toxin-A (Bot-A) was
applied at 10 d. In an alternative protocol, paralysis was induced by local
applications of 
 
a
 
-bungarotoxin (Sigma Chemical Co.; in PBS, with 0.1%
BSA; 1 
 
m
 
g on the first day, and then 0.5 
 
m
 
g every second day) onto the
gastrocnemius. Because of the potential difficulties in inducing persistent
paralysis with 
 
a
 
-bungarotoxin, we also carried out a series of experiments in
which a priming injection (1 
 
m
 
g) was followed by daily applications of 0.35 
 
m
 
g
of the toxin. In these experiments, absence of the toe-spreading reflex
was also verified daily. A third procedure consisted in applying tetrodo-
toxin (Sigma Chemical Co.; 1.2 
 
m
 
g per day in DME with 0.1% BSA) through
a sciatic nerve cuff supplied by an osmotic minipump (ALZET model
1007D; Alza Corp., Palo Alto, CA), according to a published procedure
(Witzemann et al., 1991). Depending on the paralysis protocol, paralysis
was obvious 5–24 h after the beginning of the treatment and was verified
by the missing toe-spreading reflex (gastrocnemius), as described (Witze-
mann et al., 1991). Possibly because of technical difficulties in obtaining a
tight seal at the cuff site, in most tetrodotoxin-treated animals, paralysis
signs became less obvious after 3–4 d. For crush experiments, mice were
anesthetized and the right sciatic nerve was exposed at mid-thigh level and
crushed, as described (Aigner et al., 1995).
 
Detection and Analysis of Sprouting
 
Intramuscular nerves and neuromuscular junctions were visualized on
50-
 
m
 
m cryostat sections of gastrocnemius and gluteus maximus muscle, as
described (Pestronk and Drachman, 1978
 
a
 
; Caroni et al., 1994). For the
unambiguous identification of sprouts, only nerve profiles longer than 5 
 
m
 
m
that clearly extended beyond the endplate area (ultraterminal sprouts)
were included in the analysis. At least 300 endplates per animal were ana-
lyzed as described (Aigner et al., 1995). Values are averages 
 
6
 
SEM. For
statistical analysis, the Mann–Whitney U test was applied. To provide a
measure of the total length of the sprouts in a given muscle, the lengths of
all ultraterminal sprouts and the total number of neuromuscular synapses
(including all neuromuscular junctions in a given field, i.e., those with and
without sprouts) in randomly selected fields were summed and normal-
ized to 500 neuromuscular junctions (i.e., total length of sprouts in all ran-
domly selected fields, divided by total number of neuromuscular synapses
in the same fields, times 500). Branch-points per endplate included every
silver (neurofilament)–positive side-branch of 
 
.
 
4 
 
m
 
m within the esterase-
positive synaptic region. These therefore reflect both ultraterminal sprout-
ing and the extent of terminal branching at the synapse. Not included
were branch-points from the preterminal region of the motor nerve and
from ultraterminal sprouts. Regenerative nerve growth 64 h after sciatic
nerve crush was analyzed on longitudinal 12-
 
m
 
m cryostat sections by
counting the number of neurofilament-160-positive profiles 1–2 and 5–6 mm
distal from the crush site, as described (Aigner et al., 1995). Synaptic areas
were estimated on RITC–
 
a
 
-bungarotoxin–labeled whole-mount prepara-
tions of 5–6-wk gluteus maximus muscles with NIH Image 1.4 software.
Only endplates with most of their apparent overall outlines in the plane of
focus were included in the analysis. The values are averages 
 
6
 
SEM of 75
endplates each (3 animals, 25 endplates each).
 
Results
 
Parallel Regulation of GAP-43 and CAP-23 in 
Motoneurons and at the Neuromuscular Junction
 
In 2–3-d chick embryos, CAP-23 is expressed at high levels
in most cells (Widmer and Caroni, 1990). Subsequently,
expression becomes restricted to the nervous system,
where it peaks around embryonic day 17 (Widmer and Ca-
roni, 1990). In the adult, expression is lower and is mainly
restricted to certain types of neurons. To better define the
time course of CAP-23 downregulation and to determine
whether its expression is induced upon nerve lesion, we
carried out appropriate experiments in the developing and
adult mouse neuromuscular system. Intramuscular nerve
and neuromuscular junction CAP-23 immunoreactivity
did not change significantly between birth and postnatal
day (P) 8 (data not shown). Subsequently, as shown in Fig.
1 
 
A
 
, it was downregulated between postnatal days 8 and
14, when no CAP-23 immunoreactivity could be detected
at most neuromuscular junctions. Thus, like GAP-43 (Ca-
roni and Becker, 1992), downregulation of CAP-23 in this
system coincides with the time when muscle stops growing
by the addition of new fibers and with the final phase of
synapse elimination. Fig. 1 
 
B
 
 shows nerve-associated
CAP-23 immunoreactivity in adult gastrocnemius muscle
before and 10 d after sciatic nerve crush. CAP-23 was not
detectable in adult intramuscular nerves, where it was re-
induced during regeneration. Therefore, like GAP-43
(Skene, 1989), CAP-23 is reexpressed in regenerating pe-
ripheral nerves.
 
CAP-23–overexpressing Mice Exhibit
Spontaneous and Potentiated Induced Nerve Sprouting 
at the Neuromuscular Junction
 
To determine whether the presence of CAP-23 in adult
nerves affects nerve sprouting, we produced CAP-23–
overexpressing transgenic mice. We used the same mouse
Thy1.2 expression cassette that had been used to generate
GAP-43–overexpressing mice, and that leads to neuron-
specific expression of transgene, starting around P5–10
(Aigner et al., 1995). Chick and mouse CAP-23 are highly
homologous but can be distinguished with specific anti-
bodies. Therefore, to allow for independent detection of
endogenous and transgenic CAP-23, we used chick CAP-23
as a transgene. Four independent transgenic lines with sub-
stantial expression levels in spinal motoneurons were se-
lected for further analysis. These will be designated in the
following as CAP-23(C11), CAP-23(C2), CAP-23(C17),
and CAP-23(C13). As shown in Fig. 2 
 
A
 
, transgenic CAP-23
was expressed in several types of adult neurons, including
spinal motoneurons. The data shown in the figure are from
a CAP-23(C11) mouse. Although the other transgenic
lines displayed similar widespread expression, with strong
signals in spinal motoneurons, specific differences were
noticed. However, due to the focus of this study, these
differences will not be discussed here. Fig. 2 
 
B
 
 shows that
transgene levels in homogenates of adult mouse brain
were comparable to maximal levels reached for endoge-
nous chick CAP-23. The figure also shows that mono-
clonal antibody 15C1 does not crossreact with mouse
CAP-23. Finally, Fig. 2 
 
C
 
 demonstrates that prominent
levels of chick CAP-23 immunoreactivity could be de-
tected at the adult neuromuscular junction of CAP-23(C11)
mice, whereas from P15 on endogenous CAP-23 (Fig. 2 
 
C
 
)
and GAP-43 (not shown) were undetectable. Comparable
results were obtained for the other transgenic lines in-
cluded in the analysis, with highest signals in CAP-23(C2)
and lowest signals in CAP-23(C13) mice. In situ hybridiza-
tion and Northern blot analysis failed to reveal any trans-
gene expression in muscle (data not shown). In addition,
intramuscular nerve and neuromuscular junction trans- 
The Journal of Cell Biology, Volume 136, 1997 682 
Caroni et al. 
 
Role of CAP-23 and GAP-23 in Nerve Sprouting
 
683
 
gene immunoreactivity was abolished 3 d after denerva-
tion. Taken together, these results show that, as already
described for the corresponding GAP-43–overexpressing
mice (Aigner et al., 1995), transgene expression was re-
stricted to neurons and did not activate the expression of
endogenous CAP-23 or GAP-43.
Analysis of neuromuscular innervation patterns with a
combined silver-esterase reaction revealed prominent ul-
traterminal sprouting in CAP-23–overexpressing mice
(Fig. 3, 
 
A
 
 and 
 
C
 
). Quantitative analysis revealed that the
values for the fraction of neuromuscular junctions with ul-
traterminal sprouts and the total length of ultraterminal
sprouts per muscle were comparable to those detected in
GAP-43–overexpressing mice (see Fig. 5 
 
B
 
) and higher
than those induced in nontransgenic mice by paralysis
with Bot-A (Brown, 1984) (Fig. 3 
 
C
 
). Like in GAP-43–
overexpressing mice (Aigner et al., 1995), sprouting ex-
tents and apparent local expression levels as detected by
CAP-23 immunocytochemistry were correlated. Accord-
ingly, CAP-23(C11) and CAP-23(C2) mice exhibited sub-
stantially more sprouting than CAP-23(C17) and CAP-
23(C13) mice (data not shown). Although sprouting patterns
were different, substantial sprouting was detected in all
analyzed muscles, including lateral and medial gastrocne-
mius, extensor digitorum longus, gluteus maximus, soleus,
and diaphragm. Strongest sprouting was detected in glu-
teus maximus and lateral gastrocnemius, and most of the
analysis was carried out in the gluteus muscle. Detailed
comparison with GAP-43–overexpressing mice revealed
the following differences: (
 
a
 
) In the presence of CAP-23,
sprouts were on average about three to four times longer
(Fig. 3 
 
D
 
; 
 
P
 
 
 
,
 
 0.05); (
 
b
 
) CAP-23–overexpressing mice had
fewer sprouts per endplate (about half; Fig. 3 
 
D
 
; 
 
P
 
 
 
,
 
 0.05);
and (
 
c
 
) growth cone-like enlargements were detected in
 
z
 
30% of GAP-43–induced sprouts but in 
 
,
 
5% of those
induced in the presence of CAP-23. These different quali-
tative features of the sprouting patterns in GAP-43– and
CAP-23–overexpressing mice were consistently detected
in several independent transgenic lines. As for sprouting in
the presence of GAP-43, no signs of functional denerva-
tion could be detected in the muscles of CAP-23–overex-
pressing mice. Thus, mRNAs that are induced in skeletal
muscle by denervation or paralysis in the presence of
Bot-A were not induced in any of the CAP-23–overex-
pressing mice (Fig. 3 
 
B
 
; further denervation-sensitive
mRNAs that were not induced in CAP-23–overexpressing
mice included those coding for MLP [Arber et al., 1994]
and N-CAM). In addition, intracellular recordings of
spontaneous and nerve-induced postsynaptic potentials in
nerve-muscle explants failed to reveal abnormalities in
evoked potentials, or in the amplitude of miniature end-
plate potentials (data not shown). Therefore, the presence
of CAP-23 in motor nerves and at their synaptic endings is
sufficient to induce a substantial ultraterminal sprouting
reaction in the absence of any signs of functional denerva-
tion, indicating that, like GAP-43, CAP-23 promotes spon-
taneous nerve sprouting at the neuromuscular junction.
To determine whether the presence of CAP-23 potenti-
ates induced nerve sprouting, thus producing a gain-of-
function phenotype with respect to this local nerve growth
reaction, we induced local paralysis with the presynapti-
cally acting toxin-A from 
 
Clostridium botulinum
 
 (Brown,
1984). In preliminary experiments we verified that, as for
GAP-43, muscle paralysis in the presence of Bot-A does
not induce significant CAP-23 immunoreactivity in motor
nerves or at the neuromuscular junction (data not shown),
indicating that neither GAP-43 nor CAP-23 are required
for nerve sprouting to occur. In further control experi-
ments with decreasing doses of Bot-A, we determined that
the sensitivity to Bot-A–induced paralysis was, if anything,
higher in nontransgenic than in transgenic mice. We then
analyzed nerve sprouting in 8- and 21-d-paralyzed muscles
of nontransgenic and CAP-23–overexpressing mice. As
shown in Fig. 4, 
 
A
 
 and 
 
C
 
, toxin-induced sprouting was
greatly potentiated in the presence of CAP-23. Signifi-
cantly, instead of reducing the difference between non-
transgenic and CAP-23–overexpressing mice, 3-wk paraly-
sis augmented it, leading to dramatic sprouting extents and
lengths in the presence of CAP-23 (Fig. 4 
 
C
 
). These results
indicate that the presence of CAP-23 can promote sus-
tained sprouting under favorable local conditions. They also
indicate that CAP-23 must be operating through an intrin-
sic mechanism distinct from reduced trasmitter release.
In an independent test for the effects of CAP-23 on in-
duced nerve sprouting, we analyzed short-term nerve
growth induced by sciatic nerve crush. In this experimental
paradigm, sprouting of axons into the distal section of the
lesioned nerve is assayed at a time (64 h after lesion) when
neurofilament-positive material from degenerating nerves
has been largely removed, and lesion-induced CAP-23 and
GAP-43 have not yet reached the crush site. As shown in
Fig. 4 
 
B
 
, and in further analogy to GAP-43–overexpress-
ing mice, the presence of CAP-23 significantly promoted
this form of regenerative sprouting. In contrast, reinnerva-
tion of gastrocnemius muscle 8–11 d after the crush was
not obviously faster in transgenic mice (data not shown,
but see Aigner et al., 1995, for reinnervation data in GAP-
43–overexpressing mice).
 
Figure 1.
 
Expression of CAP-23 in mouse motor nerves and at the neuromuscular junction. (
 
A
 
) At the neuromuscular junction, CAP-23
immunoreactivity is downregulated during the second postnatal week. The figure shows double-labeling immunocytochemistry of cryo-
stat sections from formaldehyde-fixed gluteus maximus muscle (equivalent photographic exposures). To visualize neuromuscular junc-
tions, the sections were counterstained with RITC–
 
a
 
-bungarotoxin. CAP-23 immunoreactivity was well detectable at P8 and nearly un-
detectable at P14. In parallel experiments, a combination of 
 
a
 
-bungarotoxin and antibody to neurofilament-160 labeled all CAP-23–
positive structures (data not shown), suggesting that in postnatal muscles, CAP-23 expression was restricted to intramuscular nerves.
(
 
B
 
) CAP-23 is reexpressed in regenerating intramuscular nerves in the adult. Double-labeling immunocytochemistry of gastrocnemius
sections from a control (
 
CON
 
) and a mouse 10 d after mid-thigh level crush of the sciatic nerve (
 
REG
 
). Note that neurofilament-160
(
 
NF-160
 
)–positive nerves do not express CAP-23 in the adult but reexpress this protein during regeneration. These findings indicate
that CAP-23 is a growth-associated protein of motor nerves. Bar, 23 
 
m
 
m. 
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Synergism between CAP-23 and GAP-43 in the 
Induction of Local Nerve Growth
 
As shown in the previous sections, the patterns of ultrater-
minal sprouting at the neuromuscular junction of GAP-
43– and CAP-23–overexpressing mice displayed consistent
differences, and both proteins are expressed in motor
nerves during development and regeneration. To deter-
mine whether GAP-43 and CAP-23 may have synergistic
activities on nerve sprouting, we analyzed offsprings of
transgenic mice crossings. Mice transgenic for GAP-43 and
CAP-23 expressed both transgenes at the neuromuscular
junction (data not shown). As shown in Fig. 5, 
 
A
 
 and 
 
B
 
,
this resulted in dramatic potentiation of nerve sprouting in
untreated animals, with long and numerous sprouts that
were detected at essentially all neuromuscular junctions.
Analysis of activity-sensitive muscle mRNAs (Fig. 5 
 
C
 
)
and of nerve muscle explants (data not shown) established
that this remarkable sprouting activity was not accompa-
nied by detectable signs of neuromuscular inactivation. In
control experiments, in mice homozygous for the GAP-43
(Fig. 5 
 
B
 
) or CAP-23 (data not shown) transgene, nerve
sprouting was comparable to that detected in correspond-
ing heterozygous mice, indicating that in these mice ele-
vating transgene levels did not lead to potentiation of
sprouting. We then determined whether the presence of
both transgenes also potentiated induced sprouting. Dou-
ble-transgenic mice displayed detectable, but compara-
tively modest potentiation of crush-induced sprouting
Figure 2. A mouse Thy1.2-based expression cassette drives expression of transgenic chick CAP-23 in adult mouse neurons, including
spinal motoneurons. (A) Neuronal expression of chick CAP-23 transgene. In situ hybridization of adult mouse (line CAP-23[C11]) brain
and spinal cord cryostat sections with digoxigenin-labeled chick CAP-23 cRNA. (Left) Strong transgene expression was detected in sev-
eral neuronal types in the hippocampal formation (e.g., dentate gyrus granule cells, hilar cells, CA1; low in CA3) and in thalamic nuclei.
No signal was detected with a corresponding sense probe (center). (Right) Strong transgene expression in spinal cord neurons (lumbar
level), including large ventral horn motoneurons (arrows). Note absence of signal in the white matter (oligodendrocytes, astrocytes). (B)
Transgene expression levels in adult mouse brain were comparable to those detected for endogenous CAP-23 in E17 chick brain, when
levels of this protein are maximal. The immunoblot of brain homogenate fractions (40 mg of protein) was probed with monoclonal anti-
body 15C1, which specifically detects chick, but not mouse (nontransgenic sample) CAP-23. The transgenic lines were CAP-23(C11),
CAP-23(C13), and CAP-23(C17). (C) Detection of transgenic, but not endogenous CAP-23 at the neuromuscular junction of a CAP-
23(C11) transgenic mouse. Double-labeling immunocytochemistry for CAP-23 and a-bungarotoxin. (Left) Section reacted with mono-
clonal antibody 15C1. (Right) Section reacted with antiserum against carboxyl-terminal sequence from mouse CAP-23 (no crossreactiv-
ity with chick CAP-23). Bar, 45 mm. 
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(data not shown). In contrast, the extent and pattern of
Bot-A–induced growth at the neuromuscular junction
were dramatically affected by the presence of both trans-
genes (Fig. 5 
 
D
 
). In addition, double-transgenic mice dis-
played a dramatic increase in the density of nerve pro-
cesses at and in the immediate vicinity of paralyzed
neuromuscular junctions. Therefore, the presence of both
GAP-43 and CAP-23 at the neuromuscular junction leads
to quantitative potentiation and qualitative alterations in
paralysis-induced sprouting.
 
Synaptic and Extrasynaptic Growth in GAP-43
(or CAP-23)–overexpressing Mice
 
The demonstration of similar and synergistic activities of
GAP-43 and CAP-23 on nerve sprouting at the adult neu-
romuscular junction strongly supports the notion that local
nerve growth is affected by the presence of intrinsic
growth-promoting components in neuronal processes.
These findings lead to questions about the range of the
structural alterations induced by the presence of these
growth-promoting proteins and the signaling mechanisms
that promote this type of growth. To begin to address the
question of whether these proteins also promote alter-
ations in synaptic structures, we visualized the distribution
of acetylcholine receptors (AChRs) in RITC–
 
a
 
-bungaro-
toxin–labeled whole-mount muscle preparations. This re-
vealed a substantial increase in the density of synaptic
structures at the neuromuscular junction of CAP-23– (Fig.
6 
 
A
 
) and GAP-43–overexpressing (Fig. 6 
 
B
 
) mice. Quanti-
Figure 3. Neuromuscular
junctions of CAP-23–overex-
pressing mice exhibit sponta-
neous nerve sprouting, with
features distinct from those
induced by GAP-43. Data
are from 4–6-wk-old mice;
gluteus maximus muscle. (A)
Ultraterminal nerve sprout-
ing in a CAP-23(C11) and a
GAP-43(wt3) mouse. The
combined silver-esterase re-
action visualizes nerves
(black) and acetylcholine es-
terase reaction product (blue;
delimiting synaptic area).
Note long ultraterminal
sprouts in the presence of
CAP-23 (arrows) and shorter
sprouts (arrows; sprout at the
bottom with growth cone
structures) in the presence
of GAP-43. (B) Contents of
denervation-sensitive mRNA
(g-subunit of AChR) in skel-
etal muscle of nontransgenic
and CAP-23(C11) mouse. As
in nontransgenic animals, the
gluteus of CAP-23(C11) mice
did not express genes in-
duced by the absence of elec-
trical activation (e.g., Bot-
A–induced paralysis [8 d;
paralyzed]). (C) Quantitative
analysis of ultraterminal
sprouting in nontransgenic
and CAP-23(C11) mice;
comparison with the sprout-
ing reaction induced in the
same type of muscle by local
paralysis (8 d) with Bot-A.
N  5 8. (D) Quantitative
analysis of nerve sprouting
patterns at the neuromuscu-
lar junction of nontransgenic (Con), CAP-23(C11), CAP-23(C2), GAP-43(wt3), and GAP-43(wt2) mice. Branch points per endplate:
silver-stained processes; sprouting and nonsprouting endplates included. For a description of the sampling and analysis procedures, see
Materials and Methods. Note distinct features of sprouting in the presence of CAP-23 (longer, less numerous sprouts) and GAP-43
(high number of branching points per endplate). Also note that “% of endplates with sprouts,” “total length of sprouts,” “mean sprout
length,” and “number of sprouts per sprouting endplate” refer to extrasynaptic branches, whereas “branch points per endplate” is a mea-
sure for branching within the endplate region, thus including intra- and ultraterminal growth. N 5 5. Bar, 57 mm.The Journal of Cell Biology, Volume 136, 1997 686
Figure 4. Potentiation of in-
duced nerve sprouting in
CAP-23–transgenic mice.
All data from 5–8-wk-old
mice; gluteus muscle or sci-
atic nerve. (A) Sprouting in
untreated and Bot-A–para-
lyzed (8 d) muscle. Analysis
as in Fig. 3 C (from which
part of the data were replot-
ted). N 5 5. (B) Regenera-
tive sprouting (at 64 h) distal
from sciatic nerve crush. N 5
4. (C) Ultraterminal nerve
sprouting in chronically para-
lyzed (3 wk) muscle. Com-
bined silver-esterase reac-
tion; the plane of focus for
the transgenic sample was se-
lected to maximize visualiza-
tion of sprouts (arrows, po-
sition of neuromuscular
junctions; in part out of fo-
cus). Note dramatic extent of
the sprouting reaction in the
CAP-23(C11) mouse and
very limited reaction in the
nontransgenic mouse. These
findings further support the
conclusion that the presence
of CAP-23 in motor nerves
produces a true gain-of-func-
tion phenotype, leading to
sustained potentiation of in-
tramuscular nerve sprouting.
Bar, 70 mm.
tative analysis of such preparations (see also Materials and
Methods) yielded the following values: estimated areas
within the outer synaptic boundaries were 1021 6 125 mm2
(control) and 962 6 106 mm2 (CAP-23[C11]); inside these
outer synaptic regions, RITC–a-bungarotoxin–positive ar-
eas were 447 6 86 mm2 (control) and 668 6 52 mm2 (CAP-
23[C11]). Significantly, no ectopic AChR clusters were de-
tected in these experiments. Since the total muscle surfaceCaroni et al. Role of CAP-23 and GAP-23 in Nerve Sprouting 687
Figure 5. Synergism between
CAP-23 and GAP-43 in nerve
sprouting induction. All data
from 4–6-wk-old mouse glu-
teus muscle. (A) Spontaneous
ultraterminal nerve sprouting
in GAP-43(wt3)-plus-CAP-
23(C11) double-transgenic mice.
Combined silver-esterase reac-
tion. Arrows point to neuro-
muscular junctions (thick) and
sprouts (thin). (B) Quantita-
tive analysis of spontaneous
ultraterminal sprouting in
heterozygous GAP-43(wt3)
and CAP-23(C11), homozy-
gous GAP-43(wt3), and dou-
ble-transgenic GAP-43(wt3)-
plus-CAP-23(C11) mice. N 5 5.
(C) Contents of denervation-
sensitive g-AChR mRNA in
gluteus muscle of double-
transgenic mice. Note absence
of denervation signs, in spite of
extensive nerve sprouting. (D)
Comparison of Bot-A–induced
nerve sprouting in nontrans-
genic, transgenic, and double-
transgenic mice. Combined sil-
ver-esterase reaction. Note
dramatic growth at and behind
neuromuscular junctions in
double-transgenic mice. In nontransgenic mice, Bot-A induced elongation of most neuromuscular junctions and detectable nerve
sprouting only at a subset of them. Some of the sprouts are indicated by arrows. Bar, 50 mm.The Journal of Cell Biology, Volume 136, 1997 688
area contained within the outer outlines of the neuromus-
cular junction was not significantly different from control,
and average muscle fiber diameters were also not altered
in the transgenic mice (data not shown), these results sug-
gest that the presence of the transgenes led to growth of
nerve processes within the synaptic region, which then in
turn induced postsynaptic structures underneath them. When
AChR configurations and silver-stained nerve processes
were compared, it became clear that although the nerve
branching index at the synapse was elevated in the trans-
genic mice (Fig. 3 D; number of branch points per end-
plate), it failed to reveal the degree of complexity detected
with RITC–a-bungarotoxin. This pointed to potential lim-
itations in the effectiveness of the silver stain method to re-
veal nerve terminal structures at the neuromuscular junc-
tion. Because the silver precipitation method mainly
reveals the presence of neurofilaments, a possible explana-
tion for these discrepancies is that fine synaptic endings
may have low contents of these neuronal cytoskeletal ele-
ments. To identify possible relations between the expan-
sion in synaptic structure density detected in GAP-43– and
CAP-23–overexpressing mice and synaptic activity, we an-
alyzed AChR configurations in Bot-A–treated muscles. 8 d
after treatment, in nontransgenic mice, paralyzing doses of
Bot-A had a very modest effect on the length of AChR-
positive synaptic branches, whereas an apparent expan-
sion in total synaptic area (from 668 6 52 mm2 to 918 6 78
mm2) was detected in transgenic mice (Fig. 6 B). Signifi-
cantly, Bot-A–induced paralysis did not induce a trans-
genic-type postsynaptic configuration in nontransgenic mice
(Fig. 6 B; with respect to this last point, similar results were
obtained upon 3-wk paralysis [data not shown]).
Multiple Activity-sensitive Mechanisms Promote Nerve 
Sprouting at the Neuromuscular Junction
What are the types of growth-inducing signals to which
GAP-43– or CAP-23–expressing terminals respond? To
begin to define relevant local mechanisms, we carried out
a detailed analysis of Bot-A–induced sprouting. The puri-
fied Bot-A used for these studies induced detectable local
signs of paralysis upon subcutaneous injection of 1 pg of
toxin over the gluteus maximus or gastrocnemius muscle
(toe-spreading reflex). A dose of 0.5 pg of toxin induced
detectable paralysis signs in about one-fifth of the mice,
and these signs were only detectable between 1 and 3 d af-
ter injection. If anything, transgenic mice were less sensi-
tive to Bot-A–induced paralysis than nontransgenic ones.
Finally, 0.3 pg of Bot-A induced no detectable signs of pa-
ralysis, and direct stimulation of the sciatic nerve 2 d after
application of toxin doses below 0.5 pg elicited gastocne-
mius twitching undistinguishable from control (untreated
animals). Therefore, although we cannot exclude that even
very low toxin levels did induce paralysis at a subpopula-
tion of neuromuscular synapses, these combined observa-
tions argue that local application of toxin doses lower than
0.3 pg failed to block nerve-induced muscle activation at
most neuromuscular junctions. In agreement with these
behavioral assessments, toxin doses lower than 1 pg failed
to induce muscle wasting or activity-sensitive mRNAs in
muscle (data not shown).
A dose-response analysis of Bot-A–induced sprouting
revealed that in GAP-43– or CAP-23–overexpressing mice
local growth reactions were already induced with 0.1 or
even 0.05 pg of toxin, i.e., with doses substantially lower than
those required to induce any signs of muscle paralysis (Fig.
7 A). Subparalyzing doses induced no detectable growth
reactions in nontransgenic mice (Fig. 7 A). In transgenic
mice, growth reactions in the absence of paralysis included
an increase in endplate branching points and the appear-
ance of numerous short ultraterminal sprouts. These reac-
tions were already detectable 24 h after toxin application
and developed to a maximal extent within 4–5 d (Fig. 7 B;
similar results were obtained with CAP-23[C11] mice).
Paralyzing doses of toxin induced similar reactions during
the first 3 d, followed by pronounced extension of ultrater-
minal sprouts, starting about 4 d after toxin application
(Fig. 7 B). Similar morphological responses were induced
when neuromuscular transmission was abolished by block-
ing nerve action potentials with a tetrodotoxin cuff placed
onto the sciatic nerve (Fig. 7 C), indicating that they were
due to impairment of evoked transmitter release and not
to effects more specifically linked to the activity of Bot-A
(i.e., cleavage of nerve terminal SNAP-25). These results
suggested that a mechanism linked to reduced calcium-
induced transmitter release from motor nerves can induce
local nerve growth in GAP-43– or CAP-23–expressing nerve
terminals. To explore this possibility, we analyzed nerve
sprouting upon local blockade of postsynaptic AChR acti-
vation with a-bungarotoxin. This paralysis-inducing para-
digm led to stimulation of ultraterminal sprout elongation,
starting 4–5 d after toxin application (Fig. 7 C). Signifi-
cantly, however, stimulation of nerve branching at the
neuromuscular junction (Fig. 7 C) and increased ultrater-
minal sprout formation (data not shown) were absent.
When 0.5 mg of a-bungarotoxin were applied daily (for 3 d),
thus subjecting the muscle to a more effective paralyzing
protocol, these early sprouting responses were also not in-
duced (data not shown). Finally, subparalyzing doses of
a-bungarotoxin were without detectable effect. As dis-
cussed below, these results are consistent with the inter-
pretation that reduced transmitter release induces local
nerve growth through a direct mechanism that may be in-
dependent of the activation of muscle AChRs and that
muscle paralysis leads to local conditions promoting the
elongation of ultraterminal sprouts. 
Discussion
We have shown that at mouse motor nerve synapses, both
GAP-43 and the related protein CAP-23 are downregu-
lated during the second postnatal week and are reinduced
by nerve lesion. Like corresponding GAP-43–overexpress-
ing mice (Aigner et al., 1995), CAP-23–overexpressing mice
displayed spontaneous and greatly potentiated induced
nerve sprouting at the adult neuromuscular junction. While
GAP-43–induced sprouts were numerous, with prominent
growth cone structures, in the presence of CAP-23 neuro-
muscular junctions displayed fewer, but longer sprouts
with barely detectable growth cones. Sprouting and its
transgene-specific features were greatly potentiated by
treatments with Bot-A, and double-transgenic mice dis-
played profound potentiation of sprouting, with structural
features reminiscent of both transgenes. These resultsCaroni et al. Role of CAP-23 and GAP-23 in Nerve Sprouting 689
Figure 6. Increased neuromus-
cular synaptic areas in GAP-
43– and CAP-23–overexpressing
mice. RITC–a-bungarotoxin
labeling of gluteus muscle fiber
whole mounts (4–6-wk-old
mice). (A) Representative ex-
amples of neuromuscular junc-
tion configurations in non-
transgenic and CAP-23(C11)
mice. Part of the nontrans-
genic endplate is out of focus,
but the entire long-axis is in fo-
cus. Note dramatic increase in
branching index and synaptic
area in the transgenic mouse.
In contrast, the external di-
mensions of the synaptic re-
gion did not differ significantly
between transgenic and non-
transgenic mice. (B) Repre-
sentative examples of neuro-
muscular junction configura-
tions in nontransgenic and
GAP-43(wt3) mice, with and
without Bot-A–induced paral-
ysis. Note that paralysis did
not induce features of trans-
genic  endplates (e.g., high
branching  index) in nontrans-
genic mice. Bar: (A) 15 mm;
(B) 29 mm.The Journal of Cell Biology, Volume 136, 1997 690
strongly support the hypothesis that mechanisms pro-
moted by intrinsic neuronal components affect the poten-
tial for and pattern of local nerve growth. 
Analysis of AChR distribution in whole-mount prepara-
tions of transgenic and nontransgenic mice with and with-
out Bot-A treatment indicated that these growth mecha-
nisms affect both extrasynaptic and synaptic structures.
Finally, experiments with paralyzing and nonparalyzing
doses of Bot-A, tetrodotoxin, and a-bungarotoxin re-
vealed that at the neuromuscular junction, growth is acti-
vated by mechanisms that may directly sense reduced
transmitter release independent of postsynaptic activity.
Muscle paralysis, in addition, greatly promotes ultratermi-
nal sprout elongation. As discussed below, a possible in-
terpretation of these findings is that at the adult neuromus-
cular junction, intrinsic neuronal components determine
competence and types of nerve growth, mechanisms sensi-
tive to nerve activity, possibly involving terminal Schwann
cells, promote nerve growth, and absence of postsynap-
tic activation leads to local conditions favoring sprout
elongation.
Characteristics and Possible Mechanisms of GAP-43/
CAP-23–potentiated Sprouting
A main finding of this study is that the patterns of sprout-
ing induced by GAP-43 or CAP-23 were different and that
expression of both proteins in double-transgenic mice
greatly potentiated nerve sprouting. The significance of
these double-transgenic results is strengthened by the fact
that, in analogous experiments, crossing of transgenic mice
expressing different phosphorylation-site mutants of
GAP-43, which did display subtle differences in nerve sprout-
ing patterns (Aigner et al., 1995), did not produce potenti-
ation of nerve sprouting (data not shown). The specific
features of the sprouting detected in the presence of the
different transgenes may have interesting biological impli-
cations. However, their interpretation will require a more
detailed analysis of sprouting in these mice, in particular
with respect to its dynamic and ultrastructural properties.
What may be the basis for the distinct and synergistic ef-
fects of GAP-43 and CAP-23 on local nerve growth? The
molecular mechanisms affected by GAP-43 are still not clear.
This cell membrane and cortical cytoskeleton–associated
protein appears to be involved in a variety of dynamic pro-
cesses at the cell periphery, including growth cone activity
(Aigner and Caroni, 1995) and guidance (Strittmatter et al.,
1995), and regulated secretion (Dekker et al., 1989; Imai-
zumi et al., 1995; Gambi et al., 1996). Potentially signifi-
cant clues are its local abundance (up to 1% of growth
cone and synaptosomal protein) and its interactions with
calmodulin, PKC, and actin filaments (Benowitz and
Routtenberg, 1987; Liu and Storm, 1990; Hens et al.,
1993). In a recent study, we found that GAP-43, CAP-23,
and a further abundant calmodulin- and actin-binding
N  5 4. (C) Endplate nerve branching is induced by blockade of
transmitter release in the presence of either Bot-A (1 pg) or tet-
rodotoxin (TTX), whereas paralyzing doses of a-bungarotoxin
(aBgtx) failed to induce this reaction. In contrast, sprout elonga-
tion was induced by all paralysis-inducing protocols. These exper-
iments were carried out in GAP-43(wt3) mice. N 5 4.
Figure 7. GAP-43– and CAP-23–transgenic mice reveal a sprout-
inducing mechanism sensitive to reduced transmitter release that
may be independent of postsynaptic activation. Data from glu-
teus (A and B) or gastrocnemius (C) muscle of 4–7-wk-old mice.
(A) Subparalyzing doses of Bot-A induce ultraterminal nerve
sprouting and elevated contents of neurofilament-positive branch
points at the neuromuscular junction. Nontransgenic (Con),
GAP-43(wt3), and CAP-23(C11) mice were analyzed. 1 pg of
Bot-A induced local paralysis in all mice, 0.5 pg failed to induce
detectable paralysis signs in .80% of the mice, and 0.1 pg in-
duced no detectable paralysis. Note that 0.05 pg of toxin was al-
ready highly effective in inducing sprouting and endplate branch-
ing (these two parameters were correlated) in GAP-43– and
CAP-23–overexpressing mice. N 5 6. (B) Time-course of Bot-A–
induced nerve growth at the neuromuscular junction of GAP-
43(wt3) mice. Sprout length: average length of the longest sprout
per sprouting endplate. Note that subparalyzing doses of the
toxin rapidly induced endplate branching (and the emergence of
short ultraterminal sprouts; data not shown), whereas paralysis
promoted sprout elongation with comparatively slow kinetics.Caroni et al. Role of CAP-23 and GAP-23 in Nerve Sprouting 691
PKC substrate, myristoylated alanine-rich C kinase sub-
strate (MARCKS) (Aderem, 1995), share a number of
unique properties, including accumulation at the same
subplasmalemmal punctate structures and induction of the
same characteristic spectrum of cell surface activities, in-
cluding blebbing and filopodia formation (Wiederkehr,
A., and P. Caroni, manuscript submitted for publication).
Like GAP-43, MARCKS has been implicated in several
processes involving cell surface dynamics, including cell
migration, phagocytosis, and exocytosis (Aderem, 1995).
Although they share certain biochemical and functional
properties, GAP-43, CAP-23, and MARCKS are clearly
regulated and targeted in very distinct manners (Skene
and Virag, 1989; Allen and Aderem, 1995). GAP-43 and
CAP-23 may thus affect similar local dynamic processes at
the cell surface, and their differential targeting and regula-
tory properties may lead to complementary and synergis-
tic effects (Wiederkehr, A., and P. Caroni, manuscript
submitted for publication). A difficulty in defining the
processes affected by these proteins is that very little is
known about the mechanisms that translate local signaling
into neurite outgrowth. However, when combined with
the fact that both GAP-43 and MARCKS have been im-
plicated in multiple motility processes at the cell surface, the
results of this study are consistent with a role for GAP-43
and CAP-23 in the processes that link cortical cytoskele-
ton dynamics to membrane fusion. One possibility is that
these proteins may shift a balance between stable mem-
brane incorporation and rapidly reversible exo-/endocyto-
sis (see e.g., Catsicas et al., 1994), thus favoring growth.
Mechanisms Regulating
GAP-43/CAP-23–mediated Plasticity
What local signaling mechanisms induce GAP-43/CAP-23–
promoted growth? As shown by the results with the pre-
and postsynaptically acting toxins, one of them appears to
be mediated by reduced transmitter release and may not
require postsynaptic nicotinic AChR activation. Although
there is evidence suggesting that reduced transmitter re-
lease could signal back to the motor nerve (Hory-Lee and
Frank, 1995), it seems very likely that the Schwann cells at
the synapse (terminal-Schwann cells) mediate this growth-
promoting signal. This is based on the fact that these cells
can respond rapidly to changes in transmitter release (Reist
and Smith, 1992; Georgiou et al., 1994) and that they ap-
pear to be causally involved in most if not all forms of
nerve sprouting at the neuromuscular junction (Reynolds
and Woolf, 1992; Son and Thompson, 1995). Out of a total
of 22 transgenic lines, we never found any evidence of trans-
gene expression in peripheral nerve or terminal-Schwann
cells. To search for signs of terminal-Schwann cell acti-
vation in the transgenic mice, we analyzed endogenous
GAP-43, GFAP, and low-affinity NGF receptor immuno-
reactivity on corresponding muscle sections. These experi-
ments did not reveal obvious differences to nontransgenic
mice (data not shown), suggesting that transgene expres-
sion may not have induced a reactive state in terminal-
Schwann cells. It therefore seems most likely that, if they
indeed mediate these growth reactions, terminal-Schwann
cells in transgenic and nontransgenic mice respond in the
same manner to reduced transmitter release, and that the
presence of GAP-43 or CAP-23 affects the subsequent
sprouting reaction. One puzzling observation was that
within the same muscle, neuromuscular junctions with vig-
orous sprouting coexisted side-by-side with junctions that
showed no detectable sprouting. This was obvious in all
transgenic lines and in paralyzed muscle from nontrans-
genic mice. Transgene presence greatly enhanced both the
extent of sprouting at single endplates and the proportion
of endplates with sprouting. Although we currently have
no explanation for this phenomenon, one possibility is that
for sprouting to occur a threshold must be reached. This in
turn may either be a property intrinsic to the nerve or may
involve both the nerve and the terminal-Schwann cell.
Functional Implications of
GAP-43/CAP-23–mediated Plasticity
Structural changes at the neuromuscular junction of GAP-
43– and CAP-23–overexpressing mice were not restricted
to presynaptic structures. In the presence of either trans-
gene, RITC–a-bungarotoxin–labeled synaptic structures
displayed a pronounced increase in branching index and
overall synaptic area. In contrast, we detected no extra-
junctional AChR clusters in these muscles, suggesting that
ultraterminal sprouts did not induce synaptic structures.
Significantly, in nontransgenic mice, treatment with Bot-A
failed to induce synaptic features resembling those in
GAP-43– or CAP-23–overexpressing mice, regardless of
the extent and duration of muscle paralysis. These results
suggest that, within the synaptic region, presynaptic
branching and growth due to the presence of GAP-43 or
CAP-23 induced corresponding growth of synaptic struc-
tures in muscle. This phenomenon is probably related to
nerve terminal outgrowth, the terminal branch elongation
reaction detected in nontransgenic mice in response to
Bot-A–induced paralysis (Pestronk and Drachman, 1978b).
In spite of these marked differences in overall synaptic
structure, we found no evidence for major functional dif-
ferences at the neuromuscular junction of transgenic and
double-transgenic mice. Functional parameters not obvi-
ously different from control included the degree of muscle
fiber polyinnervation and the amplitude and frequency of
spontaneous miniature endplate potentials (data not shown).
Although twofold and smaller changes in the frequency of
spontaneous discharges may have gone undetected in our
analysis, the results suggest that major alterations in over-
all synaptic structure were not accompanied by obvious
changes in synaptic function. This finding is consistent
with the evidence from other studies indicating that at
the neuromuscular junction, structural plasticity does not
necessarily lead to corresponding functional plasticity
(Tsujimoto et al., 1990; Stewart et al., 1996). As suggested
recently, this may reflect homeostasis of synaptic transmis-
sion (Stewart et al., 1996), possibly involving correspond-
ing changes in active zone density (Budnik et al., 1990;
Tsujimoto et al., 1990; Woytowicz et al., 1994; Stewart et al.,
1996). These questions will be adressed by an analysis of
ultrastructural parameters at the neuromuscular junction
of the transgenic mice.
Finally, because of the ease and resolution of the histo-
logical analysis and the possibilities for targeted experi-
mental manipulations, we focussed our analysis on the neu-The Journal of Cell Biology, Volume 136, 1997 692
romuscular junction. However, because of the restricted and
distinct expression of endogenous CAP-23 and GAP-43 in
the adult nervous system and the widespread expression of
CAP-23 and GAP-43 in the transgenic mice, one may pre-
dict similar effects on local nerve sprouting also in the cen-
tral nervous system. In several transgenic lines overex-
pressing GAP-43, we detected pronounced sprouting of
zinc-containing mossy fiber terminals into the pyramidal
cell layer of CA3 (Aigner et al., 1995). In spite of substan-
tial transgene expression in dentate gyrus granule cells,
none of the CAP-23–overexpressing lines displayed com-
parable massive sprouting reactions. These findings fur-
ther argue for the existence of significant functional differ-
ences between GAP-43 and CAP-23. However, because it
is technically impossible to resolve the terminal arbors of
single neurons in these experiments, the informative value
of these data is limited, and spontaneous nerve sprouting
in the adult central nervous system will have to be ana-
lyzed at a much higher resolution.
In conclusion, a substantial amount of experimental evi-
dence supports the view that terminal arborization and al-
terations in synaptic structures are involved in activity-
sensitive plasticity during development and in the adult.
The results of this study now suggest that differential ex-
pression of intrinsic neuronal components affects the ex-
tent and pattern of activity-sensitive structural plasticity in
the nervous system. The availability of transgenic mice with
greatly elevated potential for structural plasticity should
provide a valuable experimental system to study the regu-
lation and roles of structural alterations for the normal
function of the adult nervous system.
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